G92 Renal Genomics Course 2026

• 16-hour Course over 2 days
• Cost: 45 - 400 euros
• The closing date for booking a place is 26th February 2026.

Overview
Genomic testing is transforming nephrology — from diagnosing inherited kidney disease to guiding treatment, counselling families, and shaping service design.
This short course provides a practical, clinically‑focused update on the principles and practice of genomic medicine in kidney disease.
You’ll learn how to choose the right genetic test for a patient’s phenotype, interpret reports (including VUS), counsel patients and families, and apply genomics across common genetic kidney diseases including ADPKD, ADTKD and Alport syndrome.
Who this course is for
This course is suitable for:

• adult and paediatric nephrology consultants and trainees
• clinical genetics consultants and trainees
• transplant physicians and surgeons
• renal clinical nurse specialists and transplant/living donor coordinators
• genetic counsellors and allied health professionals working with kidney patients
• clinical scientists and laboratory staff involved in renal genomics

Course content
Day 1 - Fundamentals, cystic kidney disease & counselling
Thursday 5th March 2026 (09:00-17:00)
Session 1: Introduction to genomics

• A patient perspective on living with ADPKD 
• A patient perspective on living with Alport syndrome 
• Genetics in kidney disease  — DNA, types of variation, inheritance, mechanisms
• Genomic testing & variant interpretation 
• A clinical geneticist’s approach to inherited kidney disorders 

Session 2: Cystic kidney disease

• Management of ADPKD in 2025 
• Tolvaptan and upcoming clinical trials 
• HNF1B‑related kidney disease 
• ARPKD 
• Ciliopathies / nephronophthisis 
• CAKUT 

Session 3: Genetic counselling

• Counselling considerations in inherited kidney disorders 
• Small‑group case discussions
• Plenary lecture: The Generation Study
• Drinks reception

Day 2 - Tubulo‑interstitial, Alport, glomerular & other inherited disorders
Friday 6th March 2026 (09:00-17:00)
Session 1: Tubulo‑interstitial disease

• Inherited tubulopathies 
• Metabolic kidney disorders 
• ADTKD 

Session 2: Alport syndrome

• X‑linked and AR Alport syndrome 
• Heterozygous COL4A3/4 variants 

Session 3: Inherited glomerulopathies

• Genetics of nephrotic syndrome 
• APOL1‑mediated kidney disease 
• Complement‑mediated kidney disease 
• Small‑group case discussions — genetics in transplantation

Session 4: Other inherited kidney disorders

• Unexplained kidney failure 
• Tuberous sclerosis 
• Kidney cancer syndromes 

Teaching and structure

• Interactive lectures with Q&A
• All livestreamed with the ability to interact in the chat during Q&A and case based discussion.
• Patient perspectives
   
• Small‑group case discussions focused on test selection, VUS interpretation and transplant donor genomics
• Plenary lecture on large‑scale genomic research
• Networking drinks reception after Day 1

You can attend either one or both days of the course. An online-only attendance option is also available.
Certificate and accreditation
Participants will receive a Certificate of Attendance. Similar courses previously offered by the department have been accredited with 12 Category 1 (external) CPD credits by the Royal College of Physicians (UK), and we anticipate the same accreditation for this course.
Learning outcomes
At the end of the course you should be able to:

1. Recall core principles of genomics, including types of DNA variation, mechanisms of disease and inheritance patterns.
2. Understand genomic testing technologies and select the most appropriate modality for a patient’s phenotype.
3. Identify and assess individuals at risk of genetic kidney disease.
4. Conduct genetic counselling covering implications for family members, uncertainty over results and predictive testing.
5. Interpret genetic test reports, including the implications of variants of uncertain significance (VUS).
6. Describe the investigation and management of genetic kidney diseases, including ADPKD, ADTKD and Alport syndrome.
7. Recognise the impact genetic kidney disease can have on affected families.
8. Consider the present and future clinical and ethical impact of novel genomic approaches in nephrology.
9. Explore the development of local and national genomic medicine services in the NHS.

Although some of the statistics and guidelines discussed on the course are UK specific, the key concepts and learning aims are relevant internationally.
Costs and concessions
Early bird fees (until 30th November) per day

• Consultants: £220 (In Person), £180 (Online)
• Resident doctors / Physician Associates: £205 (In Person), £135 (Online)
• NHS Allied Health (CNS, etc.): £100 (In Person), £40 (Online)
• RFH / UCL / UCLH SpRs / PAs: £145 (In Person), £90 (Online)

Early bird fees (until 30th November) for two days

• Consultants: £350 (In Person), £270 (Online)
• Resident doctors / Physician Associates: £300 (In Person), £250 (Online)
• NHS Allied Health (CNS, etc.): £170 (In Person), £70 (Online)
• RFH / UCL / UCLH SpRs / PAs: £250 (In Person), £180 (Online)

Fees per day after 30th November

• Consultants: £245 (In Person), £200 (Online)
• Resident doctors / Physician Associates: £230 (In Person), £150 (Online)
• NHS Allied Health (CNS, etc.): £110 (In Person), £45 (Online)
• RFH / UCL / UCLH SpRs / PAs: £160 (In Person), £100 (Online)

Fees for two days after 30th November

• Consultants: £400 (In Person), £300 (Online)
• Resident doctors / Physician Associates: £350 (In Person), £280 (Online)
• NHS Allied Health (CNS, etc.): £200 (In Person), £80 (Online)
• RFH / UCL / UCLH SpRs / PAs: £300 (In Person), £200 (Online)

 
Course Team: 

• Professor Daniel Gale
• Dr Charlotte Barker
• Dr Zainab Arslan
• Dr Melanie Chan
• Dr Omid Sadeghi-Alavijeh